OncoMed Pharma Stock Price (NASDAQ:OMED)

Add to My Stocks
$9.13 $0.17 (1.9%) OMED stock closing price Feb 24, 2017 (Closing)
OncoMed Pharma
24 FEB 2017
amigobulls logo
OMED hand_up
OMED vs S&P 500
Closing Price: Feb 24, 2017
$9.13 ( 1.9%)
S&P 500
2367.3 ( 0.15%)
52 Week Price Range
1 Year Return: -4.17%
Q3 Growth*
Profitable ?
net image
2016 Q3 Net Loss
home image
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen

OncoMed Pharma Snapshot Video

10 5 2

OMED Stock Details

Prev Close* : $8.96
Market Cap:
Day Low: $8.95
52 Week Low: $7.41
Open: $8.95
Volume: 304056
Day High: $9.26
52 Week High: $15.49

Latest Stock Market News

Latest Articles

OncoMed Pharma News - From Partners

OMED Stockcharts

View OMED PE ratio, PS ratio stocks charts and compare with peers.
OMED Chart
Note: Compare OncoMed Pharma stock price history with the index and industry peers.

OncoMed Pharma Valuation

PS ratio (
price to sales ratio
PB ratio (
price to book ratio

OMED Industry Peers

Company Price Change (%)
Sinovac Biotech (SVA)5.680.03 (0.53%)
Organovo (ONVO)2.970 (0%)
Celgene (CELG)118.231.23 (1.03%)
Eli Lilly (LLY)82.870.32 (0.39%)
Bayer Ag (BAYRY)110.740.64 (0.57%)
Glaxosmithkline (GSK)41.560.07 (0.17%)
Verastem (VSTM)1.130.07 (5.83%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Incyte (INCY)131.219.26 (7.59%)
Sarepta Therapeutics (SRPT)32.021.87 (6.2%)
Stemline Therapeutics (STML)6.850.4 (6.2%)
Bluebird Bio (BLUE)823.7 (4.73%)
Puma Biotech (PBYI)36.21.5 (4.32%)
Sangamo BioSciences (SGMO)40.15 (3.9%)
Epizyme (EPZM)12.150.45 (3.85%)
Top gainers from Medical-Biomed-Genetics industry
* As of Feb 25, 2017
CompanyPriceChange (%)
Achillion Pharma (ACHN)3.860.38 (8.96%)
Chromadex (CDXC)2.740.13 (4.53%)
Idera Pharma (IDRA)1.670.06 (3.47%)
Inovio Pharma (INO)6.680.22 (3.19%)
VIVUS (VVUS)1.140.03 (2.56%)
Ligand Pharma (LGND)100.382.46 (2.39%)
Compugen (CGEN)4.30.1 (2.27%)
Top losers from Medical-Biomed-Genetics industry
* As of Feb 25, 2017

OncoMed Pharma Financial Statements

income statement20152014201320122011
Net Sales Or Revenues25.89M39.55M37.77M24.68M31.4M
Net Income-85.4M-50.01M-26.07M-22.23M-15.03M
Total Operating Expense111.45M90.18M61.67M47.04M46.64M
view Oncomed Pharmaceuticals Inc income statement
balance sheet20152014201320122011
Total Assets237.88M247.84M333.68M79.76M107.2M
Total Liabilities234.33M171.47M215.56M41.22M47.36M
Shareholders Equity3.55M76.36M118.12M38.54M-122.93M
view Oncomed Pharmaceuticals Inc balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities-2.13M-52.32M177.58M-13.22M1.94M
Net Cash From (Used By) Operating Activities-75.13M-84.51M144.54M-33.34M-11.28M
Increase (Decrease) In Prop Plant And Equipment-1.36M-1.77M-0.55M-0.71M-2.24M
view Oncomed Pharmaceuticals Inc cashflow statement

Oncomed Pharmaceuticals Inc Stock News - Partner Headlines

OncoMed Pharma Stock Message Board

An investor needs to spend 9.13 to buy OMED stock, as the closing OncoMed Pharma stock price is 9.13. The total market value as denoted by 332.34M for OncoMed Pharma, is the market value of the company's outstanding shares. A value investor must look at the fundamentals of a stock, and perform OncoMed Pharma valuation, even though in the short-term sentiment and current breaking news might affect OncoMed Pharma stock price.

For recognizing and analyzing the real performance of OncoMed Pharma stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. 304056 OMED shares were traded yesterday, and OncoMed Pharma stock chart shows that the OMED stock quote hit a day high of 9.26 and day low of 8.95. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. OncoMed Pharma stock price history, gives the entire historical data for OMED stock.